ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Lung Cancer
Squamous Cell Carcinoma

Melanoma trials near Austin, TX, USA:

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass)

efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...

Enrolling
Ocular Melanoma
Choroidal Melanoma
Device: Suprachoroidal Microinjector
Drug: Sham Treatment

Phase 3

Aura Biosciences
Aura Biosciences

Austin, Texas, United States of America and 45 other locations

to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma...

Active, not recruiting
Melanoma
Biological: Nivolumab
Biological: Nivolumab + Relatlimab Fixed Dose Combination

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 171 other locations

and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recur...

Active, not recruiting
Melanoma
Other: Placebo
Biological: Nivolumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 128 other locations

is safe and prevents cancer from returning in people with high-risk melanoma. Researchers want to know if V940 with pembrolizumab is better ...

Enrolling
Melanoma
Biological: Pembrolizumab
Biological: V940

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Austin, Texas, United States and 161 other locations

This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, phar...

Enrolling
Melanoma
Metastatic Cancer
Drug: Cemiplimab
Drug: Docetaxel

Phase 1, Phase 2

OncoResponse

Austin, Texas, United States and 2 other locations

The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in particip...

Active, not recruiting
Melanoma
Cancer
Biological: Ipilimumab
Other: Placebo

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Austin, Texas, United States and 74 other locations

A first-in-human study using BDC-3042 as a single agent and in combination with cemiplimab in patients with advanced malignancies

Enrolling
Melanoma
Non-small Cell Lung Cancer
Drug: Cemiplimab
Drug: BDC-3042

Phase 1, Phase 2

Bolt Biotherapeutics

Austin, Texas, United States and 4 other locations

This is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary...

Enrolling
Metastatic Solid Tumor
Drug: Pembrolizumab
Drug: PLN-101095

Phase 1

Pliant Therapeutics

Austin, Texas, United States and 4 other locations

Study of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Enrolling
Melanoma
Colorectal Carcinoma
Drug: NGM831
Drug: NGM831 plus pembrolizumab (KEYTRUDA®)

Phase 1

NGM Biopharmaceuticals

Austin, Texas, United States and 8 other locations

This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several differ...

Enrolling
Melanoma
Squamous Cell Carcinoma of the Head and Neck
Drug: pembrolizumab
Drug: brentuximab vedotin

Phase 2

Seagen
Seagen

Austin, Texas, United States and 34 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems